SpecGx, LLC recalls
2 recalls filed under SpecGx, LLC. The most recent was published January 14, 2026.
-
Class II · 9 months ago
SpecGx, LLC Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets recall: Failed Tablet/Capsule Specification: There is a potential for the imprint
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
-
Class II · 9 months ago
SpecGx, LLC Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets recall: Failed Tablet/Capsule Specification: There is a potential for the imprint
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
About this page
SpecGx, LLC appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.